Document is current

Article History

Received: 7 June 2024

Accepted: 26 September 2024

First Online: 8 October 2024

Declarations

:

: The study was approved by the Ethical Committee of Women’s Hospital, Zhejiang University School of Medicine (Hangzhou, China) (No. IRB-20230261-R). All participants or their legal representatives provided written informed consent before enrollment. The trial was registered before patient enrolment at Chinese Clinical Trial Registry with registration number ChiCTR2400079888 (date: 15/01/2024), and adhered to the CONSORT guidelines and the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.